JCI - Welcome

Conversations with Giants in Medicine

62 Articles
62 Posts

A conversation with Griffin Rodgers

Published January 4, 2021
Citation Information: J Clin Invest. 2021;131(1):e145540. https://doi.org/10.1172/JCI145540.

View: Text | PDF

A conversation with C. Ronald Kahn

Published October 1, 2020
Citation Information: J Clin Invest. 2020;130(10):5029-5030. https://doi.org/10.1172/JCI143687.

View: Text | PDF

A conversation with Jesse Roth

Published July 1, 2020
Citation Information: J Clin Invest. 2020;130(7):3331-3332. https://doi.org/10.1172/JCI138254.

View: Text | PDF

A conversation with Barbara Kahn

Published March 2, 2020
Citation Information: J Clin Invest. 2020;130(3):1053-1054. https://doi.org/10.1172/JCI136339.

View: Text | PDF

A conversation with Marc Feldmann, Jacques Miller, and Max Cooper

Marc Feldmann, Ushma S. Neill

Marc Feldmann, Ushma S. Neill

Published January 2, 2020
Citation Information: J Clin Invest. 2020;130(1):1-3. https://doi.org/10.1172/JCI134899.

View: Text | PDF

A conversation with Elaine Fuchs

Published November 1, 2019
Citation Information: J Clin Invest. 2019;129(11):4551-4552. https://doi.org/10.1172/JCI133402.

View: Text | PDF

A conversation with Lucy Shapiro

Published August 1, 2019
Citation Information: J Clin Invest. 2019;129(8):2981-2982. https://doi.org/10.1172/JCI131492.

View: Text | PDF

A conversation with George Church

Published April 1, 2019
Citation Information: J Clin Invest. 2019;129(4):1403-1404. https://doi.org/10.1172/JCI128550.

View: Text | PDF

A conversation with Mary-Claire King

Published January 2, 2019
Citation Information: J Clin Invest. 2019;129(1):1-3. https://doi.org/10.1172/JCI126050.

View: Text | PDF

A conversation with Carla Shatz

Published October 1, 2018
Citation Information: J Clin Invest. 2018;128(10):4193-4194. https://doi.org/10.1172/JCI123942.

View: Text | PDF

William Paul

William Paul, M.D., is the NIH Distinguished Investigator and Chief of the Laboratory of Immunology within the National Institute of Allergy and Infectious Diseases (NIAID).
Published April 1, 2015

Conversations with Giants in Medicine

James Rothman

For his work on vesicle transport, James Rothman shared the 2013 Nobel Prize in Physiology or Medicine.
Published February 2, 2015

Conversations with Giants in Medicine

David Nathan

David Nathan, professor at Harvard Medical School and President Emeritus of the Dana-Farber Cancer Institute, is a renowned hematologist with contributions to the clinical treatments of β-thalassemia, sickle cell disease, and chronic granulomatous disease.
Published December 2, 2014

Conversations with Giants in Medicine

Peter Agre

Peter Agre was awarded the 2003 Nobel Prize for the discovery of aquaporins. He is currently the director of the Johns Hopkins Malaria Research Institute.
Published November 3, 2014

Conversations with Giants in Medicine

Twenty-six compelling conversations

Since May 2012, the JCI has aired twenty-six interviews with twenty-eight notable scientists for the series Conversations with Giants in Medicine.
Published October 1, 2014

Conversations with Giants in Medicine

Lasker Giants

For the last five years, the JCI has had the privilege of working with the Albert and Mary Lasker Foundation to write profiles on the prizewinners. Coverage of the 2014 laureates will be featured in the October issue. In addition to the news feature...
Published September 2, 2014

Conversations with Giants in Medicine

Napoleone Ferrara

Napoleone Ferrara, of the University of California, San Diego, is best known for isolating and cloning vascular endothelial growth factor (VEGF). He then built the humanized monoclonal antibody against VEGF that led to the blockbuster drugs Avastin ...
Published August 26, 2014

Conversations with Giants in Medicine

Tony Fauci

Tony Fauci is the Director of the National Institute of Allergy and Infectious Diseases within the NIH. His work on HIV is at the forefront of infectious disease research, and he is the leader of the national discussion of infectious disease pandemi...
Published July 1, 2014

Conversations with Giants in Medicine

P. Roy Vagelos

The biochemist P. Roy Vagelos is best known for leading Merck for 20 years, first as President of research and then later as CEO and Chairman of the Board. In his time at Merck, he revolutionized the way the company approached drug discovery, introd...
Published June 2, 2014

Conversations with Giants in Medicine

Bonnie Bassler

Bonnie Bassler of Princeton University and the Howard Hughes Medical Institute has revolutionized the way that we think about microbiology. She elucidated the chemical language that bacteria use to communicate through a process called quorum sensing...
Published April 1, 2014

Conversations with Giants in Medicine

Advertisement